Dermsquared Scheduled Maintenance, Thursday Feb 29, 6:30am to 8:30am EST

On-Demand CME Videos

Baby Got JAK: Case Conversations on The Role of JAK Inhibitors in Dermatology

About

This activity was recorded at the Fall Clinical Dermatology Conference 2023. 

Baby Got JAK: Case Conversations on The Role of JAK Inhibitors in Dermatology

This activity is supported by an educational grant from Incyte.

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

December 6, 2023

Expiration Date:

December 31, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Describe the pathophysiology of itch in dermatologic conditions and how JAK inhibitors target the itch pathway

  • Outline the role of JAK inhibitors for the management of dermatologic conditions

  • Review key itch data for JAK inhibitors in skin diseases

  • Identify patients who would benefit from JAK inhibitors to manage dermatologic conditions

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Mona
Mona Shahriari, MD

Dermatologist
Central CT Dermatology
Cromwell, CT

Lisa
Lisa Swanson, MD

Pediatric Dermatologist 
Ada West Dermatology 
Boise, ID

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

Mona Shahriari, MD

Grant/Research Support: AbbVie, Dermira, Cara, Dermavant, Novartis, Union

Consultant: Abbvie, BMS, Dermavant, Leo, Lilly, Sanofi, Regeneron, UCB

Speakers’ Bureau or Honoraria: Abbvie, BMS, Lilly, Leo, Janssen, Dermavant

Lisa A. Swanson, MD

Consultant: Janssen, Lilly, Ortho Dermatologics, Sanofi-Regeneron, Pfizer, LEO, Novan, Arcutis

Speakers’ Bureau or Honoraria: Ortho Dermatologics, Pfizer, Amgen, Sanofi-Regeneron, Almirall, Janssen, Lilly, Novartis, Abbvie, Incyte 

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved